ChronosDx has developed an ultrasensitive and scalable bioassay technology for early disease detection, based on proprietary organic semiconductor technology. Their sensors have achieved world leading attomolar sensitivity, 100,000x superior to state-of-the-art immunoassay, enabling them to pick up diseases like cancer in its early stages when it is undetectable by other technologies.